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The use of primary endocrine therapy (PET) as an alternative to surgery for older women with 
operable breast cancer is common in the UK, with patient preference often reported as a factor. The 
aim of this analysis was to examine the concordance between patients’ preferred and actual 
decision styles, and their relationship with treatment received. 
Methods 
A prospective observational cohort study of women ≥70 years diagnosed with operable breast 
cancer in 56 UK units.  
Data were collected on treatment received and patients’ preferred and actual DM styles for their 
breast cancer treatment using a validated questionnaire instrument. 
Concordance between preferred and actual DM preferences was assessed using Kappa, and 
associations between age, treatment and DM style calculated using Chi-squared.  
Results 
2889 ER+ patients had data available to analyse and 2496 (86.4%) were treated with surgery, 393 
(13.6%) with PET. Preferred and actual decision preferences are shown below with concordancy 
highlighted in bold: 
Preferred 
decision type 
Actual decision type Total 
Doctor centred Shared Patient-centred 
Doctor-centred 873 130 88 1091 
Shared 236 652 186 1074 
Patient-centred 54 70 600 724 
Total 1163 852 874 2889 
Agreement = 73.6%; Kappa = 0.60, p<0.001; agreed values in bold 
 
Patients treated with PET had more patient-centred decisions (42.2%) compared surgical patients 
(42.2% vs 28.4%, p<0.001).  Discordancy (more/less involvement in the decision than desired) was 
seen in 26% (764/2889).  
 
Conclusions 
Patients had a moderate likelihood of achieving their preferred DM-style. These results suggest that 
some of the PET may be due to patient choice. 
 
 
